ORGANOGENESIS HOLDINGS INC.
ORGO US68621F1021
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced wound care, surgical and sports medicine markets. Its product category includes Advanced Wound Care and Surgical and Sports Medicine. It has single operating segment which has regenerative medicine. The company generates maximum revenue from Advanced Wound Care products. Some of its products include PuraPly Antimicrobial, Affinity, NuShield, Apligraf, Dermagraft and others.
Annual Performance 1
| 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 18% | -72% | 57% | -22% | 0% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
| Person | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Freedman Lori SR OFF |
2.99 USD |
9,022 Bought |
26,949 USD |
04/06/2025 | 06/06/2025 |
| Freedman Lori SR OFF |
2.99 USD |
9,022 Bought |
26,949 USD |
04/06/2025 | 06/06/2025 |
| Freedman Lori SR OFF |
2.91 USD |
142,379 Bought |
413,625 USD |
04/06/2025 | 05/06/2025 |
| Freedman Lori SR OFF |
2.91 USD |
142,379 Bought |
413,625 USD |
04/06/2025 | 05/06/2025 |
| Freedman Lori SR OFF |
2.82 USD |
100,863 Bought |
284,716 USD |
04/06/2025 | 04/06/2025 |
| Freedman Lori SR OFF |
2.82 USD |
100,863 Bought |
284,716 USD |
04/06/2025 | 04/06/2025 |
| Driscoll Michael Joseph |
5.10 USD |
25,000 Sold |
127,535 USD |
04/03/2025 | 04/03/2025 |
| Gillheeney Gary S. CEO |
3.49 USD |
5,585 Sold |
19,492 USD |
13/12/2024 | 16/12/2024 |
| Gillheeney Gary S. CEO |
3.36 USD |
55,615 Sold |
186,866 USD |
13/12/2024 | 13/12/2024 |
| Gillheeney Gary S. CEO |
3.55 USD |
43,359 Sold |
153,924 USD |
10/12/2024 | 12/12/2024 |